A single-center, open-label, adaptive, two-period, single oral dose, phase I study to assess the period effect (and the effect of food) on the pharmacokinetics of RO7268489 in healthy participants
Healthy Volunteers
For the latest version of this information please go to www.forpatients.roche.com